Based on these observations, we propose that CTSL is released from activated microglia via exosomes through the P2X7R/PI3K/AKT signalling pathway and that exosomal CTSL may be used as a potential biomarker of PD for early diagnosis and prognosis. Here, AKT1 is linked to Parkinson disease.